Parlodel
In brief
- Parlodel (bromocriptine) is a prescription medicine in most countries and is supplied through pharmacies and authorised online pharmacies; however, availability varies by region and in some pharmacies it may be possible to obtain Parlodel without a receipt — always check local regulations and consult a healthcare professional before purchase.
- Parlodel is used for hyperprolactinaemia, acromegaly, Parkinson’s disease and (as Cycloset in the US) adjunctive treatment of type 2 diabetes. It is a dopamine D2 receptor agonist that suppresses prolactin release, reduces growth-hormone secretion and enhances dopaminergic tone in the central nervous system.
- Usual adult dosages vary by condition: hyperprolactinaemia 1.25–2.5 mg once or twice daily (maintenance up to ~7.5 mg/day; max 15 mg/day); acromegaly starting 1.25–2.5 mg qd/bid with titration up to 20–30 mg/day; Parkinson’s typically started 1.25 mg qd/bid with usual ranges 10–40 mg/day; for diabetes (Cycloset) 0.8 mg once daily titrated to 1.6–4.8 mg/day.
- Form of administration: oral tablets (commonly 2.5 mg; 5 mg tablets available in some countries).
- Onset time: pharmacological effects begin within 1–3 hours after an oral dose (prolactin suppression can be seen within hours), though clinical benefits for some conditions may take days to weeks.
- Duration of action: effects persist for several hours; bromocriptine has a plasma Tmax of ~1–3 hours and an elimination half-life of roughly 3–7 hours, so symptomatic effects commonly last on the order of 8–12 hours depending on dose and individual response.
- Alcohol warning: avoid or limit alcohol while taking Parlodel because alcohol can increase dizziness, sedation and the risk of orthostatic hypotension.
- The most common side effect is nausea; other frequent effects include headache, dizziness/vertigo, fatigue, orthostatic hypotension, constipation and nasal congestion.
- Would you like to try parlodel without a prescription?
Basic Parlodel Information
- INN (International Nonproprietary Name): Bromocriptine
- Brand Names Available In United Kingdom: Parlodel (originator) and multiple generics supplied by manufacturers such as Novartis Sandoz, Ratiopharm, Teva and Zentiva
- ATC Code: G02CB01
- Forms & Dosages: Tablets 2.5 mg commonly; 5 mg strength exists in some countries (not universal)
- Manufacturers In United Kingdom: not specified
- Registration Status In United Kingdom: not specified
- OTC / Rx Classification: Rx only (prescription required in nearly all markets)
Market Realities And Patient Experiences (UK Pharmacy Context)
Where can someone find Parlodel in the current UK market and what do patients report?
Patients seeking parlodel (bromocriptine) in the UK encounter a mixed supply landscape with both originator and multiple generic versions present.
Major high-street chains and independent chemists commonly dispense 2.5 mg tablets in blister packs, reflecting common pack formats used across Europe.
Stock levels vary between NHS formularies, hospital contracts and private retailers, so availability can differ from one pharmacy to another.
Online pharmacies are an increasing route for patients to order parlodel, though electronic prescription verification and pharmacist counselling remain standard.
Real-World Demand And Supply
Which strengths and brands do people actually request at the counter?
Requests focus on Parlodel 2.5 mg and branded blister packs, with generics from Sandoz, Ratiopharm, Teva and Zentiva filling much of the private market demand.
Because parlodel is prescription-only, pharmacists routinely check prescriptions, counsel patients and confirm indication before supply.
NHS prescribing follows local formulary agreements, so some clinics order originator stock while others substitute generics under contract.
Patient-Reported Experience
What side effects and practical issues do real patients most commonly mention?
Many patients report nausea when starting bromocriptine, which often improves with dose adjustment or taking the tablet with food.
Dizziness on standing and fatigue are commonly mentioned, particularly during dose escalation.
Patients treated for hyperprolactinaemia often note biochemical and symptomatic improvement, but some prefer cabergoline because of less frequent dosing and a milder side-effect profile.
Practical complaints include frequent dosing during titration and concerns about cost for privately paying patients.
Visual & Content Suggestions
How to present this on a product page to help patients decide quickly?
Market Snapshot
| Access Route | Typical Pack Sizes | Patient Rating (Typical) |
|---|---|---|
| NHS / Private | 2.5 mg blister packs | 3.5–4 / 5 (varies by indication) |
Short patient quotes work well: “Nausea settled after a week” and “Switched to cabergoline for once‑weekly dosing”.
Product Summary (Pharmacy Product Card)
What essential details should a pharmacy product card include so clinicians and patients can scan rapidly?
Core Identity
The INN is bromocriptine, a dopamine D2 agonist used to suppress prolactin and, in specialist settings, growth hormone.
The ATC classification is G02CB01, under prolactin inhibitors (ergot derivatives), useful for formulary searches.
Presentation & Typical Pack
Parlodel and its generics are most commonly supplied as 2.5 mg tablets in blister packs.
A 5 mg tablet exists in some countries but is not universally supplied; 2.5 mg remains the standard in routine UK practice.
Quick Facts Block
| Item | Detail |
|---|---|
| INN | Bromocriptine |
| Strengths | 2.5 mg (common); 5 mg (limited) |
| ATC | G02CB01 |
| Prescription | Rx only |
| Principal Indications | Hyperprolactinaemia, Parkinson’s (adjunct), Acromegaly |
| Storage | Room temperature, protect from moisture and light |
| MHRA/NHS Notes | Not specified for UK registration; use local formulary guidance |
Licensed Indications And Common UK Uses
Which conditions is parlodel licensed to treat and how is it used in practice?
Main Licensed Indications
Bromocriptine is approved globally in most countries for hyperprolactinaemia, Parkinson’s disease as an adjunct and for acromegaly.
The US formulation Cycloset is a bromocriptine product licensed there for type 2 diabetes, illustrating metabolic effects of the compound.
MHRA-specific indications for the UK are not specified in the raw dataset, but worldwide approvals reflect these clinical uses.
Typical Dosing Per Condition
What doses should prescribers and pharmacists expect to see on prescriptions?
For hyperprolactinaemia, typical starting doses are 1.25–2.5 mg once or twice daily, with maintenance up to 7.5 mg per day and a maximum commonly cited at 15 mg per day.
Acromegaly and Parkinson’s dosing requires gradual titration under specialist supervision, with higher specialist doses reported in practice for acromegaly.
Practical Pharmacy Note
When handling private prescriptions, document the indication when relevant and confirm clinical suitability if outside formulary preferences.
For NHS prescriptions, check local formulary guidance and liaise with the GP or specialist where doses are high or the indication is complex.
Who Should Consider Parlodel — Patient Selection
Is parlodel the right choice for this patient sitting at the counter?
Appropriate Candidates
Suitable patients include those with hyperprolactinaemia requiring reduction of serum prolactin, some Parkinson’s patients as adjunctive therapy, and selected acromegaly patients chosen for dopamine agonist therapy.
Candidates must be able to tolerate dose escalation and accept monitoring requirements for efficacy and adverse effects.
Absolute And Relative Exclusions
Absolute contraindications include uncontrolled hypertension, severe psychotic disorders and known hypersensitivity to bromocriptine or other ergot derivatives.
Postpartum women at risk of pre-eclampsia or with eclampsia are excluded from use.
Relative cautions include cardiovascular disease, hepatic or renal impairment, history of peptic ulcer and older age due to increased CNS and hypotensive sensitivity.
Pharmacy Checklist
- Verify blood pressure and cardiovascular history before supply.
- Ask about psychiatric history and current psychotropic medications.
- Check for hepatic or renal impairment and record counselling and follow-up plan.
How To Buy Parlodel In The UK (Prescription Routes & Pharmacies)
What routes do patients use to obtain parlodel and which pharmacies commonly stock it?
Prescription Pathways
Parlodel is prescription-only, with supplies via NHS prescriptions or private prescriptions depending on the clinical scenario and local formularies.
NHS prescribing normally follows GP or specialist referral pathways, especially for Parkinson’s and acromegaly, where specialist input is typical.
Where To Purchase
Major UK chains and accredited online pharmacies commonly stock the originator and generics, though availability depends on stock and supplier contracts.
Free prescriptions apply in Scotland, Wales and Northern Ireland for eligible patients, while England follows standard NHS prescription charge rules.
Practical Buying Tips
Check pack strength before ordering — 2.5 mg is the standard for routine use.
Confirm generic manufacturer where cost is a concern; common generics include Sandoz, Ratiopharm, Teva and Zentiva.
Verify electronic prescriptions and expect pharmacist-led consultations on initiation or dose changes.
In our online pharmacy, parlodel is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
Dosage, Titration And Administration Practicalities
How should parlodel be started and what practical tips reduce side effects?
Starting And Titration Regimens
Begin at a low dose, commonly 1.25–2.5 mg daily or divided, and increase gradually according to response and tolerability.
For hyperprolactinaemia maintenance typically sits up to 7.5 mg per day, while acromegaly and Parkinson’s require slower specialist titration and higher target doses where indicated.
Administration Tips
Taking the tablet with food reduces nausea and taking larger doses at night can reduce daytime sedation for some patients.
Split doses during titration as recommended and provide clear missed-dose advice: take when remembered unless the next dose is due soon, and do not double doses.
Overdose Management
Overdose may cause vomiting, dizziness, hypotension, confusion, hallucinations and arrhythmia.
Immediate medical attention is required for suspected overdose with prompt transfer to local emergency services.
Storage, Dispensing And Handling In Pharmacy
How should parlodel be stored and what should patients be told at handout?
Storage Requirements
Store at room temperature away from excess moisture and heat, and protect from light by keeping tablets in their original blister until use.
Advise patients not to store tablets in bathrooms or other humid locations.
Dispensing Notes
Confirm batch number and expiry when supplying, and advise patients to keep blister intact until dosing to preserve stability and help adherence.
Label the supply with dosing instructions and counselling prompts, particularly for orthostatic hypotension precautions.
Visual Aids For Patients
| Storage Icon | Action |
|---|---|
| Room Temp | Keep in original blister; do not refrigerate |
| Moisture | Avoid bathrooms and humid areas |
| Disposal | Return unused tablets to pharmacy for safe disposal |
Side Effects, Monitoring And How To Manage Them
What adverse effects should patients expect and how should pharmacists monitor them?
Common Adverse Effects
Nausea is the most frequently reported side effect and tends to be dose-dependent.
Other common complaints include headache, dizziness or vertigo, fatigue, orthostatic hypotension, constipation and nasal congestion.
Digital vasospasm is rare but can present as cold fingers or toes.
Serious Or Dose-Limiting Events
Confusion and hallucinations can occur, especially in elderly patients or those on high doses for Parkinson’s disease.
Severe hypotension or cardiac events require urgent clinical review and may necessitate treatment cessation.
Monitoring Plan
| Parameter | When | Action |
|---|---|---|
| Blood Pressure | Baseline and during titration | Advise slow standing; reduce dose if symptomatic |
| Mental Health Screen | Baseline and if cognitive changes occur | Liaise with prescriber if confusion or hallucinations occur |
| Prolactin Levels | Baseline, then periodically for hyperprolactinaemia | Adjust dose according to response |
Advise patients on antiemetic strategies: take with food, consider night dosing for early doses, and report persistent nausea to the prescriber.
Interactions And Clinical Precautions
Which drugs should pharmacists check for before dispensing parlodel?
Notable Drug Interactions
Dopamine antagonists such as antipsychotics and metoclopramide oppose bromocriptine’s effect and can reduce efficacy.
Concomitant antihypertensives increase the risk of orthostatic hypotension, and combinations with other ergot derivatives require caution.
Consider hepatic enzyme effects when patients are on potent CYP inhibitors or inducers—monitor closely.
Pharmacy Safety Checks
Perform a full medication review to identify psychotropics, antiemetics, antihypertensives and any drugs affecting hepatic metabolism.
Document interactions in the patient record and contact the prescriber to agree alternatives or monitoring where necessary.
Risk Mitigation
- Stagger administration with interacting drugs where clinically acceptable.
- Counsel patients on orthostatic precautions and advise slow position changes.
- Consider switching to cabergoline if interactions or intolerance prevent effective treatment.
Comparators, Alternatives And When To Switch
When should clinicians or pharmacists consider changing from parlodel to another dopamine agonist?
Main Alternatives
Cabergoline is the most commonly used alternative for hyperprolactinaemia due to a longer half-life and generally fewer side effects.
Quinagolide is another option where available, and pergolide has been withdrawn in many countries.
When To Consider Switching
Switch if side effects are intolerable, adherence is poor because of dosing frequency, or biochemical control is inadequate on parlodel.
Switching for Parkinson’s or acromegaly should be conducted with specialist input due to complex titration needs.
Market & Formulary Considerations
| Drug | Efficacy | Dosing Frequency | Typical Formulary Status |
|---|---|---|---|
| Bromocriptine (Parlodel) | Effective, dose-dependent | Multiple daily doses during titration | Generic options; variable |
| Cabergoline (Dostinex) | Often preferred for hyperprolactinaemia | Once or twice weekly | Often preferred on formularies; higher acquisition cost |
Generics from Ratiopharm, Teva, Zentiva and Sandoz often reduce cost where formulary substitution is permitted.
Pricing, Reimbursement And Cost-Saving Options
How do prices vary and what can patients and prescribers do to keep costs down?
Cost Drivers
Price is driven by brand versus generic selection, manufacturer contracts and local NHS procurement agreements.
Generics manufactured by Ratiopharm, Teva, Zentiva and Sandoz typically offer lower-cost options compared with originator packs.
Reimbursement And NHS Routes
Prescribing for approved indications is usually reimbursed by the NHS, but local formularies may prefer generics and require justification for originator products.
Exceptional funding requests for specialist indications such as Parkinson’s or acromegaly follow trust-level processes when necessary.
Cost-Saving Tips
- Substitute generics where clinically appropriate and permitted by the prescriber.
- Prescribe common pack sizes (2.5 mg blister) to reduce dispensing complexity.
- Advise patients to compare prices across accredited online pharmacies and check entitlement to free prescriptions in devolved administrations.
Patient Counselling And Adherence Support
What should be said at supply to help patients start and stay on therapy?
Key Counselling Points
Explain the indication clearly and set expectations for the timeline of benefit, especially for hyperprolactinaemia where hormone normalisation can take weeks.
Describe common side effects such as nausea and dizziness, and discuss practical strategies: take with food, consider night dosing initially, and rise slowly from sitting or lying positions.
Adherence Strategies
Pill organisers help with divided dosing during titration, and calendar reminders support laboratory follow-up such as prolactin checks.
Pharmacy phone follow-ups in the first 2–4 weeks can identify tolerability problems early and improve persistence.
Pharmacy Tools
Provide a short counselling script for staff with prompts for baseline vitals, psychiatric screen, medication review and a follow-up schedule.
Supply a downloadable adherence checklist that reminds patients about taking with food, watching for orthostatic symptoms and returning for blood tests.
Specialist Use Cases, Off‑Label And Research Areas
Are there specialist or investigational roles for bromocriptine beyond routine practice?
Specialist Indications
Endocrinologists and neurologists may use bromocriptine for acromegaly and certain Parkinson’s regimens where dopamine agonists are indicated.
Specialist doses for acromegaly can be much higher under close monitoring, sometimes exceeding typical outpatient ranges where benefits justify risks.
Off-Label And Investigational Uses
Research has explored bromocriptine in metabolic syndrome, MAFLD and neuropsychiatric conditions, and the Cycloset formulation highlights metabolic modulation in type 2 diabetes.
These uses are investigational and should only be considered within research protocols or with specialist oversight.
Pharmacy Role
Pharmacists should flag high-dose or off‑label prescriptions, confirm specialist authorisation and ensure enhanced monitoring and documentation for patient safety.
Legal, Regulatory And Pharmacovigilance Notes
What regulatory obligations do pharmacists have when dispensing parlodel?
Regulatory Status
Bromocriptine is approved in most countries for hyperprolactinaemia, Parkinson’s disease and acromegaly, with prescription-only status in nearly all markets.
The MHRA oversees UK regulation; specific local registration details for the UK are not specified in the raw dataset.
Romania’s ANMDMR lists Parlodel and generics under BROMOCRIPTINUM for reference in international supply checks.
Pharmacovigilance Responsibilities
Report suspected adverse reactions to the Yellow Card Scheme in the UK and include batch numbers and expiry when reporting supply or manufacturing concerns.
Maintain accurate patient records to support safety monitoring and regulatory reporting.
Dispensing Compliance
- Ensure prescription legitimacy and document the indication when appropriate.
- Follow labelling, storage and standard dispensing requirements; cold-chain is not usually required for parlodel.
- Escalate any concerns about counterfeit or substandard batches and withhold supply if authenticity is doubtful.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 5–7 days |
| Birmingham | England | 5–7 days |
| Manchester | England | 5–7 days |
| Glasgow | Scotland | 5–7 days |
| Leeds | England | 5–7 days |
| Bristol | England | 5–7 days |
| Newcastle | England | 5–7 days |
| Liverpool | England | 5–9 days |
| Sheffield | England | 5–9 days |
| Edinburgh | Scotland | 5–9 days |
| Cardiff | Wales | 5–9 days |
| Belfast | Northern Ireland | 5–9 days |
| Norwich | England | 5–9 days |
| Plymouth | England | 5–9 days |
Final Practical Summary For Pharmacy Teams
What are the top takeaways to make supply safe and patient-friendly?
Confirm prescription validity and indication for parlodel and check for contraindications such as uncontrolled hypertension and severe psychotic illness.
Counsel actively about nausea, orthostatic hypotension and the need for slow titration, and provide clear missed-dose and overdose advice.
Where side effects or adherence problems arise, discuss alternatives such as cabergoline with the prescriber and document all clinical communications.
Report adverse events via the Yellow Card Scheme, keep batch details on file and guide patients on safe storage and return of unused tablets.
